M&A Deal Summary

DSM-Firmenich Acquires Unitech Industries

On July 1, 2013, DSM-Firmenich acquired food company Unitech Industries

Acquisition Highlights
  • This is DSM-Firmenich’s 7th transaction in the Food sector.
  • This is DSM-Firmenich’s 1st transaction in New Zealand.

M&A Deal Summary
Date 2013-07-01
Target Unitech Industries
Sector Food
Buyer(s) DSM-Firmenich
Deal Type Add-on Acquisition

Target

Unitech Industries

Auckland, New Zealand
Unitech Industries Ltd is a manufacture and sale of micronutrient premixes and macronutrient blends for the rapidly growing Asian Human Nutrition & Health markets. Unitech is also active in the Animal Nutrition & Health markets including premixes for pet food.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

DSM-Firmenich

Kaiseraugst, Switzerland
Category Company
Founded 1902
Sector Chemicals
Employees27,926
Revenue 10.6B EUR (2023)
DESCRIPTION

DSM-Firmenich specializes in development, manufacture and marketing of performance materials, nutritional and pharmaceutical ingredients and industrial chemicals. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics. DSM-Firmenich founded in 1902 and is based in Kaiseraugst, Switzerland.

DEAL STATS #
Overall 19 of 28
Sector (Food) 7 of 7
Type (Add-on Acquisition) 15 of 19
Country (New Zealand) 1 of 1
Year (2013) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-05-07 Yantai Andre Pectin

Yantai,, China

Yantai Andre Pectin Co., Ltd. is a China based producer of texturing ingredients. Company is active in the manufacturing and sale of apple and citrus pectin, a key food ingredient providing texture, as well as pectin related health supplements. Andre Pectin realizes .

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-11-19 Patheon BV

Durham, North Carolina, United States

Patheon BV is a global provider of pharmaceutical development and manufacturing services. With approximately 9,000 professionals worldwide, Patheon provides a comprehensive, integrated and highly customizable set of solutions to help clients of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle. A Healthier World. Delivered.

Buy $2.6B
Mergr

Product

Company

Legal